112 related articles for article (PubMed ID: 9307862)
1. Markers of vascular damage in lupus pregnancy.
Direskeneli H; Buchanan NM; Khamashta MA; Keser G; D'Cruz D; Hughes GR
Clin Exp Rheumatol; 1997; 15(5):535-9. PubMed ID: 9307862
[TBL] [Abstract][Full Text] [Related]
2. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Song J; Park YB; Lee WK; Lee KH; Lee SK
Rheumatol Int; 2000 Dec; 20(1):1-7. PubMed ID: 11149654
[TBL] [Abstract][Full Text] [Related]
3. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
4. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage.
Perry GJ; Elston T; Khouri NA; Chan TM; Cameron JS; Frampton G
Q J Med; 1993 Nov; 86(11):727-34. PubMed ID: 8265773
[TBL] [Abstract][Full Text] [Related]
5. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease.
Direskeneli H; Keser G; D'Cruz D; Khamashta MA; Akoğlu T; Yazici H; Yurdakul S; Hamuryudan V; Ozgün S; Goral AJ
Clin Rheumatol; 1995 Jan; 14(1):55-61. PubMed ID: 7743745
[TBL] [Abstract][Full Text] [Related]
6. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
Constans J; Dupuy R; Blann AD; Resplandy F; Seigneur M; Renard M; Longy-Boursier M; Schaeverbeke T; Guérin V; Boisseau MR; Conri C
J Rheumatol; 2003 Sep; 30(9):1963-6. PubMed ID: 12966599
[TBL] [Abstract][Full Text] [Related]
7. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
[TBL] [Abstract][Full Text] [Related]
8. Anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Liu MF; Lei HY
J Formos Med Assoc; 1991 Mar; 90(3):221-4. PubMed ID: 1677395
[TBL] [Abstract][Full Text] [Related]
9. The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study.
Cieślik P; Semik-Grabarczyk E; Hrycek A; Holecki M
Rheumatol Int; 2022 May; 42(5):791-801. PubMed ID: 35284968
[TBL] [Abstract][Full Text] [Related]
10. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
[TBL] [Abstract][Full Text] [Related]
11. Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies.
Lai KN; Leung JC; Lai KB; Lai FM; Wong KC
Ann Rheum Dis; 1996 Jan; 55(1):57-62. PubMed ID: 8572736
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
13. Preterm deliveries in women with systemic lupus erythematosus.
Clark CA; Spitzer KA; Nadler JN; Laskin CA
J Rheumatol; 2003 Oct; 30(10):2127-32. PubMed ID: 14528505
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
15. Increased von Willebrand factor antigen in the plasma of patients with vasculitis.
Nusinow SR; Federici AB; Zimmerman TS; Curd JG
Arthritis Rheum; 1984 Dec; 27(12):1405-10. PubMed ID: 6508862
[TBL] [Abstract][Full Text] [Related]
16. Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.
Nossent JC; Raymond WD; Eilertsen GØ
Lupus Sci Med; 2016; 3(1):e000162. PubMed ID: 27651919
[TBL] [Abstract][Full Text] [Related]
17. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
Carvalho D; Savage CO; Isenberg D; Pearson JD
Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.
D'Cruz DP; Houssiau FA; Ramirez G; Baguley E; McCutcheon J; Vianna J; Haga HJ; Swana GT; Khamashta MA; Taylor JC
Clin Exp Immunol; 1991 Aug; 85(2):254-61. PubMed ID: 1864005
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
Soff GA; Green D
J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
